Latest Asx Trading News

Page 3 of 41
Findi says it has not secured financing or restructuring terms acceptable to the relevant parties, while its cash runway remains short and its ASX suspension continues. The company cannot provide a date for lodging its FY2026 audited accounts or Annual Report.
Claire Turing
Claire Turing
21 Oct 2026
Provaris Energy has accepted $914,500 in final Share Purchase Plan applications after delayed electronic transfers pushed demand 50% above its $600,000 target. The raise will fund hydrogen and LCO₂ development, while a proposed option package still requires shareholder approval.
Maxwell Dee
Maxwell Dee
21 Oct 2026
Ramsay Health Care’s proposed separation of its 52.79% Ramsay Santé stake has reached a key regulatory milestone, with ASIC registering the Demerger Booklet. Shareholders will vote on the transaction on 24 November, but approval remains only one step in a process that could create two separately traded healthcare exposures.
Ada Torres
Ada Torres
19 Oct 2026
Cygnus Metals’ takeover by Central Asia Metals has become effective after the Supreme Court of Western Australia approved the scheme and the court orders were lodged with ASIC. Trading in Cygnus shares is being suspended ahead of implementation scheduled for 27 October.
Maxwell Dee
Maxwell Dee
15 Oct 2026
Kelly Partners Group Holdings has secured conditional ASX approval to delist, clearing a regulatory milestone in its proposed move to Nasdaq. The plan still depends on shareholder approval and the US listing process, with no effective delisting date set.
Claire Turing
Claire Turing
15 Oct 2026
Latrobe Magnesium has given eligible shareholders an additional 10 days to participate in its fully underwritten entitlement offer, citing market volatility and delays in receiving offer documents. The revised deadline is 26 October, with new shares expected to begin trading on 3 November.
Maxwell Dee
Maxwell Dee
14 Oct 2026
AXP Energy has launched a 1-for-1 non-renounceable entitlement offer seeking between A$1.2 million and A$2.249 million. The funding could support Oklahoma development, but the prospectus also highlights material going-concern uncertainty, creditor dependence and significant dilution for shareholders who do not participate.
Victor Sage
Victor Sage
12 Oct 2026
Volt Resources securities will resume trading after the company outlined a funding plan worth approximately A$6.912 million and confirmed its ongoing ASX compliance. The restart comes with two Tanzanian mining licences cancelled, limited reported cash and a proposed A$1.5 million capital raising yet to be structured.
Victor Sage
Victor Sage
8 Oct 2026
Magnetite Mines has opened a partially underwritten share purchase plan targeting approximately $1 million from eligible Australian and New Zealand shareholders. Investors who receive shares will also be entitled to one free listed option per share, subject to shareholder approval.
Maxwell Dee
Maxwell Dee
5 Oct 2026
Chimeric Therapeutics remains suspended from ASX trading after failing to lodge its FY2026 financial statements, with the company reporting an approximate $7.7 million net asset deficiency and unresolved creditor negotiations. Potential recapitalisation interest has emerged, but no binding funding or settlement agreement has been reached.
Ada Torres
Ada Torres
1 Oct 2026
ASX has suspended 15 listed companies from quotation after they failed to lodge required periodic reports by their deadlines. Trading may resume quickly if the outstanding reports are lodged, but the announcement gives no detail on the cause or length of each delay.
Victor Sage
Victor Sage
1 Oct 2026
Cluey has cancelled 3.24 million shares in a small-holder buy-back, cutting its shareholder count from 665 to 195 just days before trading is suspended and the company leaves the ASX. Investors who miss the final trading window will face a potentially illiquid private market for their shares.
Victor Sage
Victor Sage
1 Oct 2026

Browse the archive

Full archive